Objective:

To summarize the structural features of PRDM1 and its regulatory mechanisms in immune regulation, tumor progression, and inflammation-related diseases.

Approach:

Key Findings:

• PRDM1 is essential for B cell differentiation and modulates T-cell effector functions.
• Dysregulation of PRDM1 is associated with autoimmune diseases such as lupus and rheumatoid arthritis.
• Single nucleotide polymorphisms in PRDM1 may serve as biomarkers for disease diagnosis and prognosis.

Interpretation:

PRDM1 functions as a regulatory node in immune and tumor biology, with context-dependent roles in tumor suppression and promotion.

Limitations:

• The functional heterogeneity of PRDM1 across different cell types and tissue microenvironments is not fully understood, which may impact its role in disease.
• The mechanisms by which PRDM1 mediates epigenetic regulation in cancer remain unresolved.

Conclusion:

This review provides a basis for understanding PRDM1's roles in disease mechanisms.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.